Goraj; Carine

Patent Applications and Registrations

Patent applications and USPTO patent grants for Goraj; Carine.The latest application filed is for "immunogenic composition comprising staphylococcal antigens".

Company Profile

0.3.17

Goraj; Carine - Wavre BE
GORAJ; Carine - Rixensart BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immunogenic composition comprising staphylococcal antigens Grant 11,426,455 - Bagnoli , et al. August 30, 2	2022-08-30
Immunogenic Composition Comprising Staphylococcal Antigens App 20210023192 - BAGNOLI; Fabio ; et al.	2021-01-28
Immunogenic Composition For Use In Therapy App 20180104322 - BIEMANS; Ralph Leon ; et al.	2018-04-19
Method Of Treatment App 20170281744 - BIEMANS; Ralph Leon ; et al.	2017-10-05
Immunogenic Composition For Use In Therapy App 20170056490 - BIEMANS; Ralph Leon ; et al.	2017-03-02
Immunogenic Composition For Use In Therapy App 20160129101 - BIEMANS; Ralph Leon ; et al.	2016-05-12
Neisserial Vaccine Compositions Comprising A Combination Of Antigens App 20160082097 - Berthet; Francois-Xavier Jacques ; et al.	2016-03-24
Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis Grant 8,221,770 - Biemans , et al. July 17, 2	2012-07-17
Neisserial Vaccine Compositions Comprising A Combination Of Antigens App 20120064120 - Berthet; Francois-Xavier Jacques ; et al.	2012-03-15
Neisserial Vaccine Compositions Comprising A Combination Of Antigens App 20120064119 - Berthet; Francois-Xavier Jacques ; et al.	2012-03-15
Neisserial Vaccine Compositions Comprising A Combination Of Antigens App 20120027800 - Berthet; Francois-Xavier Jacques ; et al.	2012-02-02
Vaccine Compositions Comprising L2 And/or L3 Immunotype Lipooligosaccharides From Lgtb-neisseria Meningitidis App 20110033500 - Biemans; Ralph ; et al.	2011-02-10
Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB- Neisseria meningitidis Grant 7,838,014 - Biemans , et al. November 23, 2	2010-11-23
Method For Refolding Neisserial Nspa Protein App 20100291137 - Biemans; Ralph ; et al.	2010-11-18
Method for Refolding Neisserial Nspa Protein App 20080025993 - Biemans; Ralph ; et al.	2008-01-31
Purification Process for Bacterial Cytolysin App 20070231876 - Biemans; Ralph Leon ; et al.	2007-10-04
Neisserial vaccine compositions comprising a combination of antigens App 20060240045 - Berthet; Francois-Xavier ; et al.	2006-10-26
Vaccine composition App 20060057160 - Biemans; Ralph ; et al.	2006-03-16
Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis App 20060051379 - Biemans; Ralph ; et al.	2006-03-09
Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria App 20060034854 - Berthet; Francois-Xavier Jacques ; et al.	2006-02-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.